Natera launches Zenith genomics to help speed rare disease diagnosis

Natera has introduced Zenith genomics, a new genetic testing platform designed to accelerate the diagnosis of rare diseases like aromatic l-amino acid decarboxylase deficiency. Utilizing whole-genome sequencing and advanced interpretation, the platform aims to provide quicker diagnoses, better guidance for targeted therapies, and improved clinical management. This initiative, developed in partnership with MyOme, seeks to reduce the lengthy and costly diagnostic journeys often faced by rare disease patients and their families.